GSK, On Sunday, Announced First Global Phase Ib EMBOLD PanTumour-101 Data Showing Anti-Tumour Activity, Manageable Safety Profile For Ris-Rez In Relapsed ES-SCLC

뉴스 본문을 불러오고 있어요.

GSK, On Sunday, Announced First Global Phase Ib EMBOLD PanTumour-101 Data Showing Anti-Tumour Activity, Manageable Safety Profile For Ris-Rez In Relapsed ES-SCLC | 웨이프 WAPE

GSK, On Sunday, Announced First Global Phase Ib EMBOLD PanTumour-101 Data Showing Anti-Tumour Activity, Manageable Safety Profile For Ris-Rez In Relapsed ES-SCLC

기사 요약

관련 종목

댓글 —